BeOne Medicines AG (HKG:6160)
Hong Kong · Delayed Price · Currency is HKD 225.40
+7.60 (3.49%)
Sep 30, 2026, 4:08 PM HKT
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of 326.49 billion as of October 1, 2026. Its market cap has increased by 14.50% in one year.
Market Cap
326.49B
Enterprise Value
302.57B
Revenue
48.06B
Ranking
n/a
PE Ratio
63.49
Stock Price
225.40
ChartMarket Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from 6.70B to 326.49B, an increase of 4,775.39%. That is a compound annual growth rate of 43.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 326.49B | 24.77% |
| Dec 31, 2025 | 261.67B | 71.29% |
| Dec 31, 2024 | 152.77B | 4.09% |
| Dec 29, 2023 | 146.76B | -17.60% |
| Dec 30, 2022 | 178.11B | -17.96% |
| Dec 31, 2021 | 217.12B | 19.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 230.01B |
| Innovent Biologics | 170.70B |
| Sichuan Kelun-Biotech Biopharmaceutical | 116.40B |
| Genscript Biotech | 102.30B |
| Sino Biopharmaceutical | 101.69B |
| Akeso | 100.13B |
| RemeGen | 64.58B |
| Biocytogen Pharmaceuticals (Beijing) | 57.60B |